Companies › CTMX
CYTOMX THERAPEUTICS INC. (CTMX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001501989 · EDGAR filings · Updated 2026-07-27
CYTOMX THERAPEUTICS INC. (CTMX) has reported institutional ownership of 88.7%, with 179 institutional managers holding positions valued at $907.9M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-27 — SCHEDULE 13G filed
- 2026-07-27 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-06-22 — Insider transaction reported (Form 4)
- 2026-06-22 — Current report (8-K) filed
- 2026-06-22 — Insider transaction reported (Form 4)
- 2026-06-22 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CYTOMX THERAPEUTICS INC. has 179 institutional holders and institutional ownership of 88.7%.
Insider activity
Insiders reported 17 transactions (0 buys, 9 sells) across 5 reporting insiders, with a net reported value of −$1.91M.
Data flags from SEC filings
Related companies
COMPASS THERAPEUTICS INC (CMPX) · CAREDX INC (CDNA) · ARDENT HEALTH INC (ARDT) · BILLIONTOONE INC (BLLN) · ANNEXON (ANNX) · INHIBRX BIOSCIENCES INC (INBX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.